Clinical Trials on BCC in China

Total 162 results

feng xiaobin

Unknown

ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy

HCC

China
Chen Xiaoping

Recruiting

Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

HCC

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC

HCC

China
Huazhong University of Science and Technology

Unknown

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

HCC

China
RenJi Hospital
Peking University First Hospital; Fudan University; Shanghai Zhongshan Hospital; First Affiliated Hospital, Sun Yat-Sen University and other collaborators

Recruiting

Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients

Biomarkers | FH-Deficient RCC | Systemic Treatments

China
Shanghai Kanda Biotechnology Co., Ltd.

Not yet recruiting

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Other Solid Tumors | Advanced HCC

China
The First Affiliated Hospital of Zhengzhou University
Anyang Tumor Hospital; Luoyang Central Hospital; Nanyang Central Hospital; Sanmenxia... and other collaborators

Recruiting

Novel Treatment of Advanced Hepatocellular Carcinoma (NTAHCC)

HCC

China
Xuhua Duan

Recruiting

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

HCC

China
Southwest Hospital, China

Unknown

Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

HCC

China
West China Hospital

Recruiting

Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC

Immunotherapy | SBRT | Stage IV HCC

China
Zhejiang University

Unknown

Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation (HCC)

HCC

China
Southwest Hospital, China
Xijing Hospital; Xiangya Hospital of Central South University; Henan Cancer Hospital and other collaborators

Unknown

Combined Treatment of RFA and Sorafenib on Recurrent HCC (REPEAT)

HCC | Radiofrequency Ablation | Sorafenib

China
Chinese PLA General Hospital

Recruiting

Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study

HCC | Recurrence Tumor

China
Shenzhen Second People's Hospital

Recruiting

Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP

Chronic Myeloid Leukemia | Dasatinib | BCR-ABL

China
Beijing 302 Hospital

Recruiting

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Stereotactic Body Radiation Therapy | Transcatheter Arterial Chemoembolization | Large HCC Patients

China
Shanghai Jiao Tong University School of Medicine

Terminated

NeoMET Study in Neoadjuvant Treatment of Breast Cancer (NeoMET)

Safety | pCR Rate | BCT Rate

China
Sun Yat-sen University

Withdrawn

Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC

ICC

China
Akeso

Completed

A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors

HCC | Lung Cancer | Solid Tumor

China
Chinese PLA General Hospital

Recruiting

The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer

BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis

ICC

China
Tianjin Medical University Cancer Institute and...

Recruiting

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

HCC

China
West China Hospital

Active, not recruiting

RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection

HCC | HBV Coinfection

China
Sun Yat-sen University

Withdrawn

Systemic Chemotherapy Plus PD-1 for Metastasis ICC

Metastatic Cancer | ICC

China
Chen Xiaoping

Completed

VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy

Recurrence | HCC

China
The First Affiliated Hospital of Zhengzhou University
First Affiliated Hospital of Xinjiang Medical University; Anyang Tumor Hospital and other collaborators

Recruiting

Treatment of Advanced Intrahepatic Cholangiocarcinoma (TAICC)

ICC

China
Sun Yat-sen University

Not yet recruiting

Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection (DaDaLi)

HCC | Immunotherapy | Adjuvant Therapy

China
Zhongda Hospital

Completed

ISP-TACE Versus TACE for HCC With PVTT

HCC | Portal Vein Tumor Thrombosis

China
Chinese PLA General Hospital

Unknown

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Biliary Tract Cancer (BTC)

China
Shenzhen Second People's Hospital

Recruiting

TKI Discontinuation in CML Patients of China (TFR_china)

Leukemia | Myelogenous | Chronic | BCR-ABL (Breakpoint Cluster Region-abelson Murine Leukemia) | Positive

China
Peking University Cancer Hospital & Institute

Completed

The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma

HCC

China
Jiangsu HengRui Medicine Co., Ltd.

Terminated

A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC)

China
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC)

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body

Chronic Myeloid Leukemia

China
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Sunshine Lake Pharma Co., Ltd.

Terminated

KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma

Advanced HCC

China
Chen Xiaoping

Recruiting

Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma

HCC

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Tigermed Consulting Co., Ltd

Completed

Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma

HCC

China
The First Affiliated Hospital of Zhengzhou University
First Affiliated Hospital of Xinjiang Medical University; Anyang Tumor Hospital and other collaborators

Unknown

Treatment of Advanced Hepatocellular Carcinoma (TAHCC)

HCC

China
Shanghai Henlius Biotech

Withdrawn

A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC

Hepatocellular Carcinoma (HCC)

China
Meridian Bioscience, Inc.

Completed

Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

Hepatocellular Carcinoma (HCC)

China
Peking University Cancer Hospital & Institute

Recruiting

The Comparison Between HepaSphere Drug-eluting Bead Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma (HCC)

China
Guangxi Medical University

Unknown

A Study of DC-CIK to Treat Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

China
The First Affiliated Hospital of Zhengzhou University
First Affiliated Hospital of Xinjiang Medical University; Anyang Tumor Hospital and other collaborators

Unknown

Treatment of Intermediate-stage Hepatocellular Carcinoma (TIHCC)

HCC

China
Second Affiliated Hospital, School of Medicine,...

Unknown

The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular Carcinoma

HCC | Surgical Resection

China
Beijing Tsinghua Chang Gung Hospital

Unknown

Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in Treatment of Huge Hepatocellular Carcinoma (HCC) (≥10cm)

Huge Hepatocellular Carcinoma (HCC) (≥10cm)

China
Southwest Hospital, China
Xiangya Hospital of Central South University; Henan Cancer Hospital; Hunan Cancer... and other collaborators

Unknown

Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma (ESCALATOR)

HCC

China
Nanfang Hospital of Southern Medical University

Recruiting

Dasatinib Down-regulates the Expression of PD-1 and Enhances Killing pH + Leukemia Stem Cells

Chronic Myeloid Leukemia

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Bioequivalence Study of Dasatinib Tablet

Leukemia, Myelogenous, Chronic

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma (HCC)

China
First Affiliated Hospital of Harbin Medical University

Unknown

Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML Patients (HU)

Leukemia, Chronic Myeloid

China
Ascentage Pharma Group Inc.
HealthQuest Pharma Inc.

Completed

The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

Chronic Myeloid Leukemia (CML)

China

Clinical Trials on BCC in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations